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 ABSTRACT	  
Muscle adaptation to chronic resistance exercise (RE) is the result of a cumulative effect on 
gene expression and protein content. Following a bout of RE, muscle protein synthesis 
increases and, if followed by consecutive bouts (training), protein accretion and muscle 
hypertrophy develops. The protein synthetic capacity of the muscle is dictated by ribosome 
content. Therefore, the general aim of this thesis is to investigate the regulation of ribosome 
biogenesis during skeletal muscle hypertrophy. 
 
To begin addressing this question, we employed a prevalent rodent model of skeletal muscle 
hypertrophy, synergist ablation (SA) of plantar flexor muscles. SA resulted in muscle 
hypertrophy with a concomitant increase in total RNA content. We observed a marked re-
induction of c-Myc in overloaded skeletal muscle correlating with the expression of Pol I 
specific factors and 45S pre-rRNA levels. UBF and WSTF were increased at the protein 
level in myonuclei and enriched at the rDNA promoter following mechanical loading. This 
was associated with increased Pol I loading and epigenetic marks of active, de-condensed 
chromatin at the rDNA promoter.  Similarly, acute mechanical loading of human skeletal 
muscle resulted increased mTOR signaling, a re-induction of c-Myc and increased 45s pre-
rRNA abundance. Once the hypertrophic phenotype was evident in both mouse and human, 
rDNA transcription had returned to baseline levels. A conditional, skeletal muscle specific c-
Myc knockout model was generated to investigate the mechanistic importance of c-Myc in 
ribosome biogenesis and hypertrophy. Animals lacking c-Myc in skeletal muscle displayed 
normal post-natal development with respect to body weight, muscle size, rDNA 
transcription and RNA content. To further challenge the growth machinery in skeletal 
muscle lacking c-Myc, animals were subjected to SA-imposed overload. No difference with 
respect to RNA accumulation or hypertrophic response was detected, indicating that c-Myc 
is dispensable for cellular hypertrophy in terminally differentiated muscle cells. These 
results were verified in C2C12 myotubes with compromised c-Myc function (Myra-A). On 
the contrary, c-Myc inactivation in proliferating C2C12 myoblasts severely compromised 
rDNA transcription, DNA synthesis as well as cell proliferation. Thus, our data suggests cell 
stage-specific effects of ablated c-Myc function in cells of the myogenic lineage. Moreover, 
the importance of the mTOR network for rDNA gene regulation during skeletal muscle 
hypertrophy was investigated. mTOR inhibition using rapamycin prevented the development 
of hypertrophy, and decreased mTOR binding to rDNA correlated with decreased 45S pre-
rRNA synthesis and perturbed rRNA accumulation. Selective inhibition of RNA Pol I with 
CX-5461 efficiently prevented skeletal muscle hypertrophy in a similar fashion. 
 
Collectively, the data presented in this thesis proposes an important role for ribosome 
biogenesis at the onset of skeletal muscle hypertrophy, which, if blocked, prevents the 
development of the hypertrophic phenotype. During the time in which measurable 
hypertrophy is evident, rRNA synthesis rates have normalized. In addition, our results 
indicate that mTOR regulates this process via numerous different mechanisms, including 
direct binding to the rDNA promoter but likely not via p70S6K1-dependent functions. c-
Myc proved dispensable for Pol I transcription and skeletal muscle hypertrophy in the 
differentiated state both in vivo and in vitro, instead controlling cell proliferation in 
myoblasts, likely via a Pol I-dependent mechanism. 
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